OCCIDENT – The Science Investor.

AI Verified

Location

Germany


Investor type

Family Office


Current investment status

00 00 00


Website

https://www.occident.group/


Linkedin

00 00 00


Submission link

00 00 00


Company address

22 Klenzestraße, 80469 Munich, Bavaria, Germany


Founding year

2012


Twitter

00 00 00


Facebook

00 00 00

Criteria Requirements Match
Regions North America, Northern Europe, Southern Europe, Western Europe
00
Countries
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Sector
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Impact Area
00 00 00
Stage Series A, Seed, Series B, Growth Stage
00
Ticket size
00 00 00
-
00 00 00
USD
00
Monetization model
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Product readiness
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Client types
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
00
Min. revenue
00 00 00
USD
00
Other
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
-

Unlock Free Premium Insights

Discover how well you match with this investor and reach out on the Raise Better platform.

  • Advanced matching algorithm
  • Detailed compatibility scores
  • Priority investor access
Create Free Account

Company description

OCCIDENT – The Science Investor. With a dedicated focus on deep technology ventures emerging from scientific research, OCCIDENT strategically positions itself as a catalyst for innovations addressing contemporary societal challenges. This owner-managed venture capital firm operates from dual headquarters in Munich and Zug, providing not just financial backing but comprehensive support to promising startups. Their investment philosophy centers on identifying solutions with tangible impact potential, particularly within the realms of life sciences and industrial technologies.

Distinguished by their seed-stage investment approach, OCCIDENT establishes long-term partnerships with portfolio companies, offering both capital resources and invaluable industry expertise. This commitment to extended engagement enables founding teams to achieve remarkable outcomes in their respective fields. Unlike traditional venture capital entities, OCCIDENT invests proprietary funds, allowing for autonomous decision-making based on sustainable success metrics rather than short-term gains. Their investment strategy prioritizes ventures demonstrating scientific excellence coupled with commercial viability.

The OCCIDENT team embodies a profound entrepreneurial spirit, drawing inspiration from the innovative founding teams they support. Their collaborative methodology fosters intensive knowledge exchange, creating a dynamic environment where challenges are addressed collectively. This hands-on approach has resulted in a diverse portfolio spanning breakthrough medical technologies, sustainable industrial solutions, and cutting-edge scientific applications. The firm has developed particular expertise in navigating the complex journey from laboratory research to market-ready products.

At its core, OCCIDENT's investment philosophy is guided by a dual commitment to financial returns and positive societal impact. Each investment decision is evaluated not only for its commercial potential but also for its contribution to sustainable development. This principled approach has positioned OCCIDENT as a respected partner within the European deep tech ecosystem, particularly for scientifically-driven ventures seeking investors who understand the unique challenges of research commercialization. Their portfolio demonstrates a consistent pattern of supporting innovations that address critical needs in healthcare, environmental sustainability, and industrial efficiency.

Highlights

Investing in deep tech start-ups with focus on spin-offs
Supporting life sciences and industrial tech from seed stage

Ready to raise better?

Create your Free Account!

Frequently asked questions

Where is OCCIDENT – The Science Investor. located?

OCCIDENT – The Science Investor. maintains its global headquarters in Germany, serving as the strategic center for its operations. The company's primary corporate offices are located at 22 Klenzestraße, 80469 Munich, Bavaria, Germany.

What investment stages OCCIDENT – The Science Investor. focuses on?

OCCIDENT – The Science Investor. focuses its investment activities on companies operating in the following stages: Series A, Seed, Series B, Growth Stage. OCCIDENT – The Science Investor. provides strategic capital and expertise to support promising businesses at these critical phases of development.

Where does OCCIDENT – The Science Investor. invest?

OCCIDENT – The Science Investor. maintains a strategic global investment presence, actively seeking opportunities across the following key regions: North America, Northern Europe, Southern Europe, Western Europe.

When was OCCIDENT – The Science Investor. founded?

OCCIDENT – The Science Investor. was established in 2012, marking the beginning of its journey as an investment firm.

What kind of investment firm is OCCIDENT – The Science Investor.?

OCCIDENT – The Science Investor. is the following type of investment firm: Family Office. The organization provides capital and strategic support to entrepreneurs and growing companies.